Birmingham Psychiatry Pharaceutical Studies, Inc. — Birmingham, Alabama

Birmingham Psychiatry Pharaceutical Studies, Inc. is a clinical research site located in Birmingham, Alabama, United States 35226.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Birmingham Psychiatry Pharaceutical Studies, Inc. has participated in 1 clinical trials.

Therapeutic areas: Generalized Anxiety Disorder.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Birmingham Psychiatry Pharaceutical Studies, Inc.?

Birmingham Psychiatry Pharaceutical Studies, Inc. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Birmingham Psychiatry Pharaceutical Studies, Inc. conducted?

Birmingham Psychiatry Pharaceutical Studies, Inc. has 1 clinical trials on record. Their work covers Generalized Anxiety Disorder.

Is Birmingham Psychiatry Pharaceutical Studies, Inc. accredited by Crixeo Health?

Birmingham Psychiatry Pharaceutical Studies, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Birmingham Psychiatry Pharaceutical Studies, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.